Difference between revisions of "Vinblastine (Velban)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "{| border="1"" to "{| class="wikitable"")
Tags: mobile edit mobile web edit
Line 58: Line 58:
 
[[Category:Drugs]]
 
[[Category:Drugs]]
 
[[Category:Intravenous medications]]
 
[[Category:Intravenous medications]]
[[Category:Vesicant chemotherapy]]
+
[[Category:Vesicant]]
 
[[Category:Microtubule inhibitors]]
 
[[Category:Microtubule inhibitors]]
 
[[Category:Vinca alkaloids]]
 
[[Category:Vinca alkaloids]]

Revision as of 22:30, 7 December 2019

General information

Class/mechanism: Vinca alkaloid, inhibits microtubule formation in the mitotic spindle, causing cell cycle arrest in metaphase.[1][2]
Route: IV
Extravasation: vesicant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Diseases for which it is used

Also known as

  • Generic names: chlorhexamide, vinblastine sulfate, vinblastine sulphate, vincaleukoblastine, VLB
  • Brand names:
Synonyms
Alkaban-AQ Blastovin Cellblastin Cytoblastine Erbablas
Exal Faulblastina Lemblastine Periblastine Rabinefil
Velban Velbastine Velbe Vinblasin Vinblastin
Vinblastina

References